Portage Biotech Inc (PRTG)
$0.2
Market is closed - opens 7 PM, 29 Jul 2024
Performance
- $0.19$0.20$0.20
3.95%
Downside
Day's Volatility :3.95%
Upside
0.0%
- $0.13$3.25$0.20
34.35%
Downside
52 Weeks Volatility :95.96%
Upside
93.85%
Returns
| Period | Portage Biotech Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -18.23% | 6.5% | 0.0% |
6 Months | -76.59% | 7.1% | 0.0% |
1 Year | -93.58% | 9.8% | 0.0% |
3 Years | -98.8% | 14.2% | -20.2% |
Highlights
Market Capitalization | 3.8M |
Book Value | $1.62 |
Earnings Per Share (EPS) | -8.52 |
Wall Street Target Price | 7.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -9.13% |
Return On Equity TTM | -145.19% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -18.9M |
Diluted Eps TTM | -8.52 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.65 |
EPS Estimate Next Year | -0.52 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Sell
0
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Portage Biotech Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
- Current
- 1M Ago
- 3M Ago
Buy
00
00
00
Hold
3
3
3
Sell
3
3
3
Analyst Forecast
What analysts predicted
Upside of 3400.0%
Current $0.20
Target $7.00
Technicals Summary
Sell
Neutral
Buy
Portage Biotech Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Portage Biotech Inc | -11.13% | -76.59% | -93.58% | -98.8% | -99.46% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Portage Biotech Inc | NA | NA | NA | -0.65 | -1.45 | -0.09 | NA | 1.62 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Portage Biotech Inc | Sell | $3.8M | -99.46% | NA | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Portage Biotech Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 155.2%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 285.3%
Institutional Holdings
Armistice Capital, LLC
8.42%Lakeview Capital Partners, LLC
1.08%PEAK6 INVESTMENTS LP
0.28%Millennium Management LLC
0.17%Renaissance Technologies Corp
0.16%BlackRock Inc
0.16%
Company Information
portage biotech inc is a company based out of canada.
Organization | Portage Biotech Inc |
Employees | 7 |
CEO | Dr. Ian B. Walters M.B.A., M.D. |
Industry | Healthcare |
